469 related articles for article (PubMed ID: 31381562)
1. Distinct roles of RAD52 and POLQ in chromosomal break repair and replication stress response.
Kelso AA; Lopezcolorado FW; Bhargava R; Stark JM
PLoS Genet; 2019 Aug; 15(8):e1008319. PubMed ID: 31381562
[TBL] [Abstract][Full Text] [Related]
2. The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells.
Hromas R; Kim HS; Sidhu G; Williamson E; Jaiswal A; Totterdale TA; Nole J; Lee SH; Nickoloff JA; Kong KY
Breast Cancer Res; 2017 Nov; 19(1):122. PubMed ID: 29145865
[TBL] [Abstract][Full Text] [Related]
3. DNA polymerase θ (POLQ) is important for repair of DNA double-strand breaks caused by fork collapse.
Wang Z; Song Y; Li S; Kurian S; Xiang R; Chiba T; Wu X
J Biol Chem; 2019 Mar; 294(11):3909-3919. PubMed ID: 30655289
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous Targeting of DNA Polymerase Theta and PARP1 or RAD52 Triggers Dual Synthetic Lethality in Homologous Recombination-Deficient Leukemia Cells.
Sullivan-Reed K; Toma MM; Drzewiecka M; Nieborowska-Skorska M; Nejati R; Karami A; Wasik MA; Sliwinski T; Skorski T
Mol Cancer Res; 2023 Oct; 21(10):1017-1022. PubMed ID: 37358557
[TBL] [Abstract][Full Text] [Related]
5. The RAD52 S346X variant reduces risk of developing breast cancer in carriers of pathogenic germline BRCA2 mutations.
Adamson AW; Ding YC; Mendez-Dorantes C; Bailis AM; Stark JM; Neuhausen SL
Mol Oncol; 2020 Jun; 14(6):1124-1133. PubMed ID: 32175645
[TBL] [Abstract][Full Text] [Related]
6. Targeting the DNA Repair Enzyme Polymerase θ in Cancer Therapy.
Schrempf A; Slyskova J; Loizou JI
Trends Cancer; 2021 Feb; 7(2):98-111. PubMed ID: 33109489
[TBL] [Abstract][Full Text] [Related]
7. A role for human homologous recombination factors in suppressing microhomology-mediated end joining.
Ahrabi S; Sarkar S; Pfister SX; Pirovano G; Higgins GS; Porter AC; Humphrey TC
Nucleic Acids Res; 2016 Jul; 44(12):5743-57. PubMed ID: 27131361
[TBL] [Abstract][Full Text] [Related]
8. DNA polymerase θ (POLQ), double-strand break repair, and cancer.
Wood RD; Doublié S
DNA Repair (Amst); 2016 Aug; 44():22-32. PubMed ID: 27264557
[TBL] [Abstract][Full Text] [Related]
9. Spatiotemporal dynamics of homologous recombination repair at single collapsed replication forks.
Whelan DR; Lee WTC; Yin Y; Ofri DM; Bermudez-Hernandez K; Keegan S; Fenyo D; Rothenberg E
Nat Commun; 2018 Sep; 9(1):3882. PubMed ID: 30250272
[TBL] [Abstract][Full Text] [Related]
10. Pan-cancer analysis of co-occurring mutations in RAD52 and the BRCA1-BRCA2-PALB2 axis in human cancers.
Hamid AB; Frank LE; Bouley RA; Petreaca RC
PLoS One; 2022; 17(9):e0273736. PubMed ID: 36107942
[TBL] [Abstract][Full Text] [Related]
11. Rad52 competes with Ku70/Ku86 for binding to S-region DSB ends to modulate antibody class-switch DNA recombination.
Zan H; Tat C; Qiu Z; Taylor JR; Guerrero JA; Shen T; Casali P
Nat Commun; 2017 Feb; 8():14244. PubMed ID: 28176781
[TBL] [Abstract][Full Text] [Related]
12. Mammalian RAD52 Functions in Break-Induced Replication Repair of Collapsed DNA Replication Forks.
Sotiriou SK; Kamileri I; Lugli N; Evangelou K; Da-Ré C; Huber F; Padayachy L; Tardy S; Nicati NL; Barriot S; Ochs F; Lukas C; Lukas J; Gorgoulis VG; Scapozza L; Halazonetis TD
Mol Cell; 2016 Dec; 64(6):1127-1134. PubMed ID: 27984746
[TBL] [Abstract][Full Text] [Related]
13. Co-inhibition of pol θ and HR genes efficiently synergize with cisplatin to suppress cisplatin-resistant lung cancer cells survival.
Dai CH; Chen P; Li J; Lan T; Chen YC; Qian H; Chen K; Li MY
Oncotarget; 2016 Oct; 7(40):65157-65170. PubMed ID: 27533083
[TBL] [Abstract][Full Text] [Related]
14. A postincision-deficient TFIIH causes replication fork breakage and uncovers alternative Rad51- or Pol32-mediated restart mechanisms.
Moriel-Carretero M; Aguilera A
Mol Cell; 2010 Mar; 37(5):690-701. PubMed ID: 20227372
[TBL] [Abstract][Full Text] [Related]
15. POLθ-mediated end joining is restricted by RAD52 and BRCA2 until the onset of mitosis.
Llorens-Agost M; Ensminger M; Le HP; Gawai A; Liu J; Cruz-García A; Bhetawal S; Wood RD; Heyer WD; Löbrich M
Nat Cell Biol; 2021 Oct; 23(10):1095-1104. PubMed ID: 34616022
[TBL] [Abstract][Full Text] [Related]
16. Small-Molecule Disruption of RAD52 Rings as a Mechanism for Precision Medicine in BRCA-Deficient Cancers.
Chandramouly G; McDevitt S; Sullivan K; Kent T; Luz A; Glickman JF; Andrake M; Skorski T; Pomerantz RT
Chem Biol; 2015 Nov; 22(11):1491-1504. PubMed ID: 26548611
[TBL] [Abstract][Full Text] [Related]
17. The function of RAD52 N-terminal domain is essential for viability of BRCA-deficient cells.
Hanamshet K; Mazin AV
Nucleic Acids Res; 2020 Dec; 48(22):12778-12791. PubMed ID: 33275133
[TBL] [Abstract][Full Text] [Related]
18. Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile.
Cramer-Morales K; Nieborowska-Skorska M; Scheibner K; Padget M; Irvine DA; Sliwinski T; Haas K; Lee J; Geng H; Roy D; Slupianek A; Rassool FV; Wasik MA; Childers W; Copland M; Müschen M; Civin CI; Skorski T
Blood; 2013 Aug; 122(7):1293-304. PubMed ID: 23836560
[TBL] [Abstract][Full Text] [Related]
19. Human somatic cells deficient for RAD52 are impaired for viral integration and compromised for most aspects of homology-directed repair.
Kan Y; Batada NN; Hendrickson EA
DNA Repair (Amst); 2017 Jul; 55():64-75. PubMed ID: 28549257
[TBL] [Abstract][Full Text] [Related]
20. Single-Strand Annealing in Cancer.
Blasiak J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
